Carvalho André F, McIntyre Roger S, Dimelis Dimos, Gonda Xenia, Berk Michael, Nunes-Neto Paulo R, Cha Danielle S, Hyphantis Thomas N, Angst Jules, Fountoulakis Konstantinos N
Department of Clinical Medicine and Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Department of Psychiatry and Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada.
J Affect Disord. 2014 Jul;163:56-64. doi: 10.1016/j.jad.2014.03.035. Epub 2014 Mar 28.
Predominant polarity (PP) is a proposed course specifier for bipolar disorder, which was not incorporated in the DSM-5 as a descriptor for the nosology of bipolar disorder (BD). Here we perform a systematic review of original studies about PP.
A computerized search of MEDLINE/Pubmed, EMBASE and Web of Science databases from inception to October 6th, 2013 was performed with keywords, including 'bipolar disorder', 'polarity' and 'predominant polarity'.
A total of 19 studies met inclusion criteria. A unifying definition and conceptualization for PP is lacking. A PP is found in approximately half of BD patients. Most studies that included type I BD patients found the manic PP to be more prevalent, while studies that included type II BD participants found a higher prevalence of depressive PP. The depressive PP has been consistently associated with a depressive onset of illness, a delayed diagnosis of BD, type II BD and higher rates of suicidal acts. The manic PP is associated with a younger onset of illness, a first episode manic/psychotic and a higher rate of substance abuse. Evidence suggests that PP may influence responses to acute treatment for bipolar depression. Furthermore, evidences indicate that PP should be considered for the selection of maintenance treatments for BD.
There are few prospective studies on PP. There were disparate definitions for PP across studies.
The concept of PP provides relevant information for clinicians. Future studies should investigate the genetic and biological underpinnings of PP.
优势极性(PP)是双相情感障碍一种提议的病程说明符,但在《精神疾病诊断与统计手册》第五版(DSM - 5)中未被纳入作为双相情感障碍(BD)疾病分类的描述符。在此,我们对关于PP的原始研究进行系统综述。
使用包括“双相情感障碍”“极性”和“优势极性”等关键词,对MEDLINE/Pubmed、EMBASE和Web of Science数据库从创建到2013年10月6日进行计算机检索。
共有19项研究符合纳入标准。PP缺乏统一的定义和概念化。约半数BD患者存在PP。大多数纳入I型BD患者的研究发现躁狂PP更为普遍,而纳入II型BD参与者的研究发现抑郁PP的患病率更高。抑郁PP一直与疾病的抑郁发作、BD的延迟诊断、II型BD以及更高的自杀行为发生率相关。躁狂PP与疾病的较年轻起病、首次发作躁狂/精神病以及更高的药物滥用率相关。有证据表明PP可能影响双相抑郁急性治疗的反应。此外,有证据表明在选择BD的维持治疗时应考虑PP。
关于PP的前瞻性研究较少。各研究中PP的定义存在差异。
PP的概念为临床医生提供了相关信息。未来研究应调查PP的遗传和生物学基础。